IOVANCE BIOTHERAPEUTICS, INC. Income Taxes Paid
IOVANCE BIOTHERAPEUTICS, INC. (IOVA) reported Income Taxes Paid of $0 for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-24.
Financial Statements › Cash Flow › Other Cash Flow Items
us-gaap:IncomeTaxesPaidNet · last filed 2026-02-24
- IOVANCE BIOTHERAPEUTICS, INC. income taxes paid, net for the quarter ending 2017-12-31 was $0.00.
- IOVANCE BIOTHERAPEUTICS, INC. income taxes paid, net for the quarter ending 2017-09-30 was $0.00.
- IOVANCE BIOTHERAPEUTICS, INC. income taxes paid, net for the quarter ending 2017-06-30 was $0.00.
- IOVANCE BIOTHERAPEUTICS, INC. income taxes paid, net for the quarter ending 2017-03-31 was $0.00.
- IOVANCE BIOTHERAPEUTICS, INC. income taxes paid, net for fiscal 2025 was $0.00.
- IOVANCE BIOTHERAPEUTICS, INC. income taxes paid, net for fiscal 2024 was $0.00.
- IOVANCE BIOTHERAPEUTICS, INC. income taxes paid, net for fiscal 2023 was $0.00.
- IOVANCE BIOTHERAPEUTICS, INC. income taxes paid, net for fiscal 2018 was $0.00.
| Period end | Income Taxes Paid, Net 3 month | Income Taxes Paid, Net 6 month | Income Taxes Paid, Net 9 month | Income Taxes Paid, Net 12 month |
|---|---|---|---|---|
| 2025-12-31 | $0.00 10-K · filed 2026-02-24 | |||
| 2024-12-31 | $0.00 10-K · filed 2026-02-24 | |||
| 2023-12-31 | $0.00 10-K · filed 2026-02-24 | |||
| 2018-12-31 | $0.00 10-K · filed 2019-02-28 | |||
| 2017-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-28 | $0.00 derived: sum of 2 quarters · filed 2019-02-28 | $0.00 derived: sum of 3 quarters · filed 2019-02-28 | $0.00 10-K · filed 2019-02-28 |
| 2017-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-02 | $0.00 derived: sum of 2 quarters · filed 2017-11-02 | $0.00 10-Q · filed 2017-11-02 | $0.00 derived: sum of 4 quarters · filed 2019-02-28 |
| 2017-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-03 | $0.00 10-Q · filed 2017-08-03 | $0.00 derived: sum of 3 quarters · filed 2019-02-28 | $0.00 derived: sum of 4 quarters · filed 2019-02-28 |
| 2017-03-31 | $0.00 10-Q · filed 2017-05-03 | $0.00 derived: sum of 2 quarters · filed 2019-02-28 | $0.00 derived: sum of 3 quarters · filed 2019-02-28 | $0.00 derived: sum of 4 quarters · filed 2019-02-28 |
| 2016-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-28 | $0.00 derived: sum of 2 quarters · filed 2019-02-28 | $0.00 derived: sum of 3 quarters · filed 2019-02-28 | $0.00 10-K · filed 2019-02-28 |
| 2016-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-02 | $0.00 derived: sum of 2 quarters · filed 2017-11-02 | $0.00 10-Q · filed 2017-11-02 | |
| 2016-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-03 | $0.00 10-Q · filed 2017-08-03 | ||
| 2016-03-31 | $0.00 10-Q · filed 2017-05-03 | |||
| 2015-12-31 | $0.00 10-K · filed 2018-03-12 | |||
| 2015-06-30 | $0.00 10-Q · filed 2016-08-09 | |||
| 2014-12-31 | $0.00 10-K · filed 2017-03-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Adaptive Biotechnologies Corp (ADPT) | United States | $4.719B | -53.43 |
| CRISPR Therapeutics AG (CRSP) | $5.390B | -11.68 | |
| Relay Therapeutics, Inc. (RLAY) | United States | $3.884B | -14.30 |
| Scholar Rock Holding Corp (SRRK) | United States | $5.920B | -16.37 |
| CG Oncology, Inc. (CGON) | United States | $6.095B | -27.95 |
| Tarsus Pharmaceuticals, Inc. (TARS) | United States | $3.329B | -58.60 |
| Denali Therapeutics Inc. (DNLI) | United States | $3.274B | -8.04 |
| Immunovant, Inc. (IMVT) | United States | $7.028B | -14.78 |
| Beam Therapeutics Inc. (BEAM) | United States | $2.549B | -41.51 |
| Greenland Mines Ltd (GRML) | United States | $2.362B |